T
Turnstone Biologics Corp
NASDAQ:TSBX
Turnstone Biologics Corp
NASDAQ:TSBX
Price:
0.355
USD
Market Cap:
$8.2m
Cash Flow Statement
Cash Flow Statement
Turnstone Biologics Corp
Turnstone Biologics Corp
Currency: USD
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(40)
|
(57)
|
(55)
|
(75)
|
(75)
|
(74)
|
(71)
|
(63)
|
|
| Depreciation & Amortization |
5
|
5
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
8
|
9
|
4
|
4
|
4
|
4
|
4
|
3
|
|
| Other Non-Cash Items |
15
|
17
|
4
|
3
|
3
|
1
|
2
|
4
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Change in Working Capital |
(66)
|
(70)
|
(18)
|
3
|
2
|
5
|
0
|
0
|
|
| Cash from Operating Activities |
(86)
N/A
|
(105)
-22%
|
(66)
+37%
|
(66)
0%
|
(68)
-2%
|
(66)
+2%
|
(67)
-1%
|
(57)
+15%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(6)
|
(6)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
|
| Other Items |
11
|
(31)
|
(27)
|
(30)
|
(14)
|
52
|
79
|
65
|
|
| Cash from Investing Activities |
5
N/A
|
(37)
N/A
|
(28)
+24%
|
(30)
-9%
|
(15)
+52%
|
52
N/A
|
79
+51%
|
64
-18%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
0
|
78
|
78
|
78
|
78
|
(0)
|
0
|
0
|
|
| Other |
(4)
|
(4)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
(4)
N/A
|
75
N/A
|
77
+3%
|
78
+1%
|
78
+0%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
(85)
N/A
|
(68)
+20%
|
(17)
+75%
|
(19)
-11%
|
(4)
+78%
|
(15)
-255%
|
11
N/A
|
7
-33%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(92)
N/A
|
(111)
-21%
|
(67)
+39%
|
(67)
+1%
|
(68)
-2%
|
(67)
+2%
|
(68)
-1%
|
(57)
+16%
|
|
Switch to:
Switch to:
See Also
Discover More
